Maharashtra, India. snake venom poisoning for animal experiment. The root of Vitex trifolia is

Similar documents
6/20/2018. A Public Benefit Corporation. A First-in-Class Snakebite Antidote. Discovery to Accelerated Development

STATE TOXINOLOGY SERVICES Toxinology Dept., Women s & Children s Hospital, North Adelaide SA 5006 AUSTRALIA

Delayed reporting to health care facilities: a significant determinant of fatalities in cases of snake bites

Epidemiological profile of snake bite at tertiary care hospital, East India

Clinical Profile of Envenomation in Children With Reference To Snake Bite

Materials and Methods: Anti-snake venom activities of Asparagus racernosus

Neutralization of Micrurus distans distans venom by antivenin (Micrurus fulvius)

Snake-Bite Present Scenario In Bangladesh. Dr A K M Humayon Kabir Associate professor Dept. of Medicine Dhaka Medical College

Clinical Profile of Snake Bite in Children in Rural India. Vinayak Y. Kshirsagar, MD; Minhajuddin Ahmed, MD; Sylvia M.

Error! Reference source not found. I. SUMMARY OF PRODUCT CHARACTERISTICS

WHO/SEARO GUIDELINES FOR THE CLINICAL MANAGEMENT OF SNAKE BITES IN THE SOUTHEAST ASIAN REGION

CLINICAL PROFILE OF SNAKE BITE CASES IN MARATHWADA, INDIA

Gye and Cramer (1919) found that the ionizable salts of calcium injected together with the washed spores of Cl. tetani or of certain

By the end of this lecture students will be able to understand Importance, epidemiology, pathogenesis of snake bite Clinical manifestations

5 Dangerous Venom Types Thailand Snakes. Thailand Snake Venom Types:

Clinical profile and outcome of snake bite in children

IJBCP International Journal of Basic & Clinical Pharmacology

Procedure # IBT IACUC Approval: December 11, 2017

Characteristics of snake envenomation in eastern India, a study of epidemiology, complications and interventions

DOWNLOAD OR READ : THE POISONOUS SNAKES OF INDIA FOR THE USE OF THE OFFICIALS AND OTHERS RESIDING IN THE INDIAN EMPIRE PDF EBOOK EPUB MOBI

3 RD INTERNATIONAL SUMMIT ON TOXICOLOGY & APPLIED PHARMACOLOGY OCTOBER 20-22, 2014 CHICAGO, USA

SUMMARY OF PRODUCT CHARACTERISTICS. Pentoject, Pentobarbitone Sodium 200 mg/ml Solution for Injection

Scientific Discussion post-authorisation update for Rheumocam extension X/007

SNABIRC-KENYA A GUIDE TO MANAGING SNAKEBITES

DOWNLOAD OR READ : SNAKE BITE PDF EBOOK EPUB MOBI

Ayurvedic Aspect of Alark (Rabies) A Peer Review

SUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur...

Use of oral Cotrimoxazole and injectable Gentamicin in module 6 & 7 of ASHA program

Snake Bite Kit Caution!

Dosing Your Cat with Azithromycin Pediatric Suspension. By Lorraine Shelton

POST-OPERATIVE ANALGESIA AND FORMULARIES

DEWORMING PROCESS KRISHIMATE AGRO AND DAIRY PVT LTD NO.1176, 1ST CROSS, 12TH B MAIN, H A L 2ND STAGE, INDIRANAGAR BANGALORE , INDIA

2012 National FFA Veterinary Science CDE Math Practicum KEY

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

. Analgesics and antipyretics (tabkt mefanemic acid

Health Products Regulatory Authority

See Important Reminder at the end of this policy for important regulatory and legal information.

Summary of Product Characteristics

SUMMARY OF PRODUCT CHARACTERISTICS

Malayan Pit Viper Venomous Very Dangerous

SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

For the treatment of infections caused by a wide range of Gram-positive and Gramnegative pathogenic bacteria including:

= 0.5 mg. In vitro toxin neutralisation test based on haemolysis of sheep erythrocytes. For a full list of excipients, see section 6.1.

UT HEALTH EMERGENCY MEDICINE & TRAUMA GUIDELINES

Envenomation by the hump nosed viper (hypnale hypnale) in children: a pilot study

Summary of Product Characteristics

MARBOCYL 10% SUMMARY OF PRODUCT CHARACTERISTICS

TOXOIDING OF SNAKE VENOM AND EVALUATION OF IMMUNOGENICITY OF THE TOXOIDS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Venomous Snakes in Florida: Identification and Safety

Venomous Snakebite in Mountainous Terrain: Prevention and Management

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

Venomous Snakes of Northeast Florida. Del Webb Men s Club October 22, 2015

Super Toxic Thailand Sea Snakes

Clinical Features, Management and Outcome of Snake Bite in Children in Manipal Teaching Hospital

PG 600. S ame time. same place. The management tool in swine reproduction

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

VENOMOUS SNAKE BITES IN LAO PDR: A RETROSPECTIVE STUDY OF 21 SNAKEBITE VICTIMS IN A PROVINCIAL HOSPITAL

66 ISSN East Cent. Afr. J. surg

Ear drops suspension. A smooth, uniform, white to off-white viscous suspension.

SUMMARY OF PRODUCT CHARACTERISTICS. NUFLOR 300 mg/ml solution for injection for cattle and sheep

Spiders and Snakes Martin Belson, MD

(D) fertilization of eggs immediately after egg laying

VENOMS OF CORAL SNAKES (MICRURUS SPP.): REPORT ON A MULTIVALENT ANTIVENIN FOR THE AMERICAS

SUMMARY OF PRODUCT CHARACTERISTICS

Venomous Snakes Of The World By Mark O'Shea

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

SUMMARY OF PRODUCT CHARACTERISTICS

STATE TOXINOLOGY SERVICES Toxinology Dept., Women s & Children s Hospital, North Adelaide SA 5006 AUSTRALIA

Irish Medicines Board

SUMMARY OF PRODUCT CHARACTERISTICS. Euthasol vet. 400 mg/ml, solution for injection (AT, BE, DK, EE, EL, FI, IE, IS, LT, LU, LV, NO, PL, RO SE, UK)

Metacam. The Only NSAID Approved for Cats in the US. John G. Pantalo, VMD Professional Services Veterinarian. Think easy. Think cat. Think METACAM.

In vitro effect of some Indian honeys on Staphylococcus aureus from wounds

PROFESSIONAL PRACTICE STANDARD

STANDARD OPERATING PROCEDURE #110 MOUSE ANESTHESIA

Clinical Profile and Outcome of Envenomous Snake-Bite At Tertiary Care Centre In Nellore- A Retrospective Study

FREEDOM OF INFORMATION (FOI) SUMMARY

AGENDA NOTES FOR THE MEETING OF COMMITTEE FOR THE PURPOSE OF CONTROL AND SUPERVISION EXPERIMENTS ON ANIMALS (CPCSEA) VENUE : COMMITTEE ROOM NO.

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Emdocam 20 mg/ml solution for injection for cattle, pigs and horses

International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access.

Statistical Analysis of Nipah Virus Using R

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/18

The Institutional Animal Care and Use Committee (IACUC) Aquatic Animals: Analgesia and Anesthesia formulary

MARBOCYL FD SUMMARY OF PRODUCT CHARACTERISTICS

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

PART IB1 SUMMARY OF PRODUCT CHARACTERISTICS OCTACILLIN

SUMMARY OF PRODUCT CHARACTERISTICS

Snake bites in north east Sri Lanka

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

EXCEDE Sterile Suspension

PACKAGE LEAFLET: INFORMATION FOR THE USER. Amikacin 250 mg/ml Injection

SUMMARY OF PRODUCT CHARACTERISTICS

Snakes on the Plain. Copperhead. By Brooke Cain

SUMMARY OF PRODUCT CHARACTERISTICS. Active substance: Imidacloprid 40 mg/pipette (0.4 ml of a 10 % solution)

New Zealand Consumer Medicine Information

The Most Venomous Dangerous Deadly Poisonous Snakes?

Antibiotic Prophylaxis in Spinal Surgery Antibiotic Guidelines. Contents

Transcription:

Research Article International Ayurvedic Medical Journal ISSN:2320 5091 IN VIVO STUDY OF THE EFFICACY OF SINDUVAARAKA MOOLA AGADA (ROOT OF VITEX TRIFOLIA) AS A FIRST AID MEASURE IN SNAKE VENOM POISONING Chougule Savita B 1, Joglekar V.P. 2 1 Asso. Prof., Departmentt of Agadtantra, RIARCH,Mayani, Satara, Maharashtra, India 2 HOD & Prof. PG Department of Agadtantra, Tilak Ayurved Mahavidylaya, Pune, Maharashtra, India ABSTRACT Snakebites are a major healthh threat in India. If patient need any medical or any other treatment they have to go to Higher Medical Centre. Hence we require the primary substitution or first aid measure before serotherapy, i.e. Poly-Valent Anti-Snake Venom Serum (PVASVS), which will increase the survival period and decrease the mortality and morbidity. We have selected Sinduvaaraka Moola Agada mentioned in Ashťaamga Samgraha in snake venom poisoning for animal experiment. The root of Vitex trifolia is triturated in swarasa of the same and mixed with honey. 1 This agada given by oral route is beneficial in elapidae snake venom poisoning. (A.S.U.Sarpavishapratished adhyaya 42/21)..Sinduvaaraka moola agada is useful as a first aid measure in snake venom because, it delays the onset of symptoms in Common cobra and Russell s viper venom. It increases the survival period in Common cobra and Russell s viper venom. It does not interact with Poly Valent Anti Snake Venom Serum (PVASVS). KEY WORDS: first aid, Snakebite, Sinduvaaraka Moola Agada.. INTRODUCTION About 2 million people are bitten by snakes annually of which 15,0000 to 30,000 cases prove fatal. Snake bite cases are more common in the states of Maharashtra, west Bengal, Uttar Pradesh, Assam & Ker- vali- ala. Currently the only scientifically dated treatment for snake venom enveno- Anti-Snake Venom Serum (PVASVS), it is mation is serotherapy i.e. Poly-Valent available at Rural Hospital., Public Health Centre, Government Hospital. 2 When a snake bites the patient, it takes time to raise alarm. First aid help will arrive within 10 min.then they arrange a Van, Bullock-cart or any other vehicle to reach to PHC or RH. This traveling will take average 2-2.5 hrs. When patient reaches to PHC or RH it may not be OPD timing, doctors may not be available at that time, since snakebite, cases are more common at night. After ar- will start, rival of doctors serotherapy which will require minimum 30 min.therefore, the average time lapse will be 3 hrs 10 min. Average fatal period of Common cobra is 2-3 hrs, Krait 6-12 hrs, Viper is 24 hrs. After irreversible damage by venom poisoning, serotherapy will not be able to rescue the patient, delay in treatment may turn to be fatal. Hence, we require the primary substitution or first aid measure before serotherapy, which will increase the survival period and decrease

the mortality and morbidity. In snakebite cases available first aid measures are, physical and external i.e. pressure bandage, application of tourniquet, incision and suction, hence there effectiveness is limited. 3 So we require a first aid measure for snake bite, that will be a) A first aid measure should be safe i.e. nontoxic. b) Its route of administration should be oral, because nasal or collyrium application will require trained person and it will time consuming. c) It should be easy to available, easy to prepare, easy to administer. d) It should prolong the appearance of symptoms or prolong the survival time, so that patient can get serotherapy before irreversible changes should happen. e) The most important factor in first aid measure was that it should not interact with PVASVS. Snake are classified into neurotoxic, vasculotoxic and myotoxic. Myotoxic snakes are sea snakes, these are less common. Out of neurotoxic and vasculotoxic Common cobra and Russells viper poisoning is more common. 4 So we wanted to see the efficacy of drug on Common cobra venom and Russell s viper venom poisoning. We have selected Sinduvaaraka Moola Agada mentioned in Ashťaamga Samgraha in snake venom poisoning.the root of Vitex trifolia is triturated in swarasa of the same and mixed with honey. This agada is given by oral route is beneficial in elapidae snake venom poisoning.route of administration of Sinduvaaraka Moola Agada is oral. Ashťaamga Samgraha states that this remedy is effective in Darveekara (elapidae) type of snake venom poisoning. 5 In India Cobra and Russell s viper are more common. Therefore, it is necessary to check the efficacy of said remedy in both types of poisoning. AIMS AND OBJECTIVES: To study the efficacy of Sinduvaaraka moola agada in Common cobra venom poisoning as a first aid measure. To study the efficacy of Sinduvaaraka moola agada in Russell s viper venom poisoning as a first aid measure. To study whether there is any adverse drug reaction between Sinduvaaraka moola agada and Poly Valent Anti Snake Venom Serum (PVASVS). MATERIAL AND METHODS: Collection of Sinduvaaraka moola Raw sample of Sinduvaaraka moola was collected from Sangli. Authentification of Sinduvaaraka was done at Botanical Survey of India Pune. Preparation of Sinduvaaraka moola Agada- 6 In a clean washed Morter & Pestle 100gm Powder of sinduvaaraka moola was taken,then the juice of sinduvaaraka patra was added to it. The trituration process was continued for day and night until it became a thin slurry. became a dry powder,then only it was considered as one Bhaavanaa was completed.like this total 7 Bhaavanaas were given to that powder. For each Bhaavanaa process freshly prepared juice of sinduvaaraka was used. After completion of 7 Bhaavanaa Greenish coloured Sinduvaaraka moola agada was obtained. Standardizations of Drug This study was done at Indian Drug Research Association Laboratory, Pune. Collection of AGMARK standard Madhu - AGMARK standard honey was collected from Mankarnika aushdhaalaya,pune. Collection of Snake Venom - Dried lyophilized form of 110 mg of Common cobra venom and 90 mg of Russell s viper venom was collected from 637

Snake farm, Haffkine Institute For Training Research and Testing, Mumbai. Details are as per following: Collection of Poly Valent Anti Snake Venom Serum (PVASVS)- PVASVS was procured from Haffkine Institute for Training Research & Testing, Mumbai. Experimental study Conversion factor from man to mice was 0.0026 so according to this venom dose, drug (Sinduvaaraka moola agada) dose and PVASVS dose was calculated. Dose calculation of Venom: Human fatal dose for Common cobra is 12 mg. 7 According to conversion factor mice fatal dose for Common cobra venom was 0.0312 mg i.e. 31.2 ugm. Previously total fatal dose was taken but at this dose no death occurs in Albino mice. So After doing pilot Study following dose was taken. Dose of Common cobra venom was =60 ugm. Human fatal dose for Russell s viper is 20 mg. 8 According to conversion factor mice fatal dose for Russell s viper venom was 0.0520 mg i.e. 52 ugm. Previously total fatal dose was taken but at this dose no death occurs in Albino mice till 7 days. After doing pilot study following dose was taken. Dose of Russell s viper venom was = 750ugm. Dilution criteria for venom : Dried lyophilized form of venom was diluted to get appropriate fatal dose to inject mice. In a vial of 110 mg cobra venom 11 ml distilled water was added, from that 0.125 ml was removed and added to 5 ml distilled water containing glass bottle. Then it was sealed with rubber cork. From this dilution 0.24 ml was taken out and injected to mice. 100 mg 10ml 1 ml = 10 mg 638 1250 ugm. 5ml 60 ugm.= 0.24ml In a vial of 90 mg Russell s viper venom 9 ml distilled water was added, form that 5 ml was removed and added to 2.5 ml distilled water containing glass bottle.it was sealed with rubbre cork. From this dilution 0.38 ml was taken out and injected to mice. 90 mg 9 ml 1 ml = 10 mg 5000 ugm. 2.5ml 750 ugm.= 0.38ml Dose calculation of Sinduvaaraka moola agada: Dose of Churńa in Śhaarangadhar samhitaa was given as 1 Karsha 9 i.e.10gm.but for todays time period it is too high. So ideal dose of Churńa was taken as 1gm. Human dose of Sinduvaaraka moola agada was 1gm. According to conversion factor mice dose was 0.0026gm i.e.2.6mg. For that purpose 130mg of Sinduvaaraka moola agada was weighed on balance and 130mg of Madhu was mixed then15ml distilled water was added to it.this mixture was stirred for 15 min and good suspension was made. Out of this 0.3 ml was given for oral dose. Dose Calculation of PVASVS: 1 ml of reconstitute PVASVS neutralizes 0.6 mg of Common cobra venom. 10 For our animal experiment, we gave 60 ugm.of Common cobra venom. So required dose of PVASVS was 0.1 ml Dose of PVASVS for Common cobra Group = 0.1 ml 1 ml of reconstitute PVASVS neutralizes 0.6 mg of Russell s viper venom. 11 For our animal experiment we gave 750 ugm.of Russell s viper venom. So required dose of PVASVS was 1.25 ml Dose of PVASVS for Russell s Viper Group = 1.25 ml Animal Experiment

Animal species Source of Animals Avg. Wt. of mice No. of Animals Age of Animals Sex of Animals No. of groups. 8 Dosing Snake venom was given by Intramuscular route, Sinduvaaraka moola agada was given by Oral route and PVASVS was given by Intravenous route. Table no 1- Protocol used Table no 2- Groups for Animal Experiments Group I (Control Group) Group II Group III (Control Group) Group IV Group V (Standard Group) PVASVS Method : a) Samples were converted into Suspension by through mixing with water b) Samples were freshly prepared for each group and then administered. c) Doses given to Animals according to their body weight. d) After dosing all animals were observed for 24 hours for toxic signs and symptoms or mortality up to 7 days. Procedure: a) First preliminary drug toxicity study was done. b) In each group, weight of animal was taken first, accordingly route venom dose was given by IM route, after 5 min, drug dose was given by orally route and then PVASVS was given after 5 min by IV route. 639 Albino Mice NTC, Pune 22 gm. 3 mice in each group 6 8 wks. Female in each group Only Common cobra venom. Common cobra venom + Sinduvaaraka moola agada Only Russell s viper venom Russell s viper venom + Sinduvaaraka moola agada Common cobra venom + PVASVS Group VI Common cobra venom + Sinduvaaraka moola agada + PVASVS GroupVII(Standard Group) Russell s viper venom + PVASVS Group VIII Russell s viper venom + Sinduvaaraka moola agada + c) After dosing animals were observed for 24 hrs up to 7 days. d) Comparative observations were tabulated. OBSERVATIONS OF IN - VIVO STUDY : 1. Appearance of tremors were delayed by 10 min in common cobra venom +Sinduvaaraka moola agad group. 2.Appearance of paralysis was delayed by 15 min in common cobra venom + Sinduvaaraka moola agada group. 3.Appearance of convulsions was delayed by 19min in common cobra venom + Sinduvaaraka moola agada group. 4. Duration of Survival was delayed by 29min in common cobra venom +Sinduvaaraka moola agada group.

640 5. Duration of Survival was delayed by 39min in Russell s viper venom + Sinduvaaraka moola agada group. 6.Group V (Standard Common cobra group) :- One mice died after 197 min., this may be due to serum sickness reaction of PVASVS. Remaining two mice survived completely. 7.Group VI -All three mice survived completely without showing any signs. 8.Group VII (Standard Russell s viper group )-All three mice survived completely without showing any signs. 9.Group VIII :- All three mice survived completely without showing any signs. RESULTS: Sinduvaaraka moola agada is useful as a first aid measure in snake venom because, It delays the onset of symptoms in Common cobra-tremors- P Value(One tail) = 0.048170538,Convulsion-P Value(One tail)= 0.039824615, Paralysis-P Value(One tail)= 0.046171657 It delays the survival period in Common cobra- P Value(One tail)= 0.015518475 It delays the survival period in Russell s viper- P Value(One tail)= 0.014562386 It dose not interact with Poly Valent Anti Snake Venom Serum (PVASVS) DISCUSSION Dose calculation we conducted the pilot study using two animal per dosage group. In the first stage these animals were given 25,50&100 ugm (in Russell s viper) & 12.5,25&50 ugm ( in cobra group) dose levels of venom respectively.at this level in cobra group 50% animal died in 50 ugm.but in Russell s viper group no fatality or observable morbidity was seen.the reason for this discrepancy may be loss of potency of venom during storage. Therefore in Russell s viper group two more stages by increasing venom doses are carried,& at 750 ugm fatality was seen. Therefore to achive good observation period 60 ugm of cobra venom &750 ugm of Russell s viper venom was used. Observations appearance of tremors was observed after 36 min (average) and that of drug group (Gr. II) was after 46 min (average) i.e. appearance of tremors was delayed by 10 min in Sinduvaaraka moola agada group,which is statistically significant. P value is 0.04(one tail). appearance of paralysis was observed after 43min (average) and that of drug group (Gr. II) it was after 58 min (average) i.e. appearance of paralysis was delayed by 15 min in Sinduvaaraka moola agada group,which is statistically significant. P value is 0.04(one tail). appearance of convulsions was after 48 min (average) and in drug group (Gr. II) it was observed after 67 min (average) i.e. appearance of convulsions was delayed by 19 min in Sinduvaaraka moola agada group,which is statistically significant. P value is 0.03(one tail). duration of survival was 59 min (average) & that of drug group (Gr. II) duration of survival was 88 min (average) i.e. duration of survival was delayed by 29 min in Sinduvaaraka moola agada group,which is statistically significant. P value is 0.01(one tail). In Common cobra venom + PVASVS (standard group) one mouse died after197min. This may be due to serum sickness reaction of PVASVS. Remaining two mice survived completely.

In Common cobra venom + Sinduvaaraka moola agada + PVASVS group (Gr. VI) all mice survived completely without showing any signs. In Russell s viper venom group (Gr. III) duration of survival was 121min (average) & that of drug group (Gr. II) duration of survival was 160 min (average) i.e. duration of survival was delayed by 39 min in Sinduvaaraka moola agada group,which is statistically significant. P value is 0.01(one tail). In Russell s viper venom + PVASVS group (Gr. VII), all mice survived without showing any symptoms. In Russell s viper venom + Sinduvaaraka moola agada + PVASVS group (Gr. VIII), all mice survived without showing any symptoms. No adverse interaction between Sinduvaaraka moola agada and PVASVS was seen. Significant Results Ashťaamga Samgraha states that this remedy is effective in Darveekara (elapidae) type of snake venom poisoning. But It was proved efficient in Russell s viper venom poisoning also.the results of survival period in Russell s viper venom group was proved to be statistically significant. P value is 0.01(one tail)the results of survival period in Common cobra venom group was proved to be statistically significant. P value is 0.01(one tail) CONCLUSION The Present study confirms the Vishaghna property i.e.antiophidian property of the Sinduvaaraka moola agada.sinduvaaraka moola agada is useful as a first aid measure in snake venom because, It delays the onset of symptoms in Common cobra and Russell s viper venom. It increases the survival period in Common cobra and Russell s viper venom. It does not interact with Poly Valent Anti Snake 641 Venom Serum (PVASVS). Thus the null hypothesis is rejected and the hypothesis that Sinduvaaraka moola agada is efficient as a first aid measure in Common cobra and Russell s viper venom is accepted. REFERENCES 1. Ashťaamg Samgraha, Lalachandra Śhashtri Vaidya, Vaidyanath Aayurved Bhavan, Nagpur, 1988. 2. Harrison s Principals of Internal Medicine Vol II 14 th Edition 1998. 3. Parikh s textbook of Medicinal Jurisprudence, 4. Parikh s textbook of Medicinal Jurisprudence, 5. Ashťaamg Samgraha, Lalachandra Śhashtri Vaidya, Vaidyanath Aayurved Bhavan, Nagpur, 1988. 6. Ratarngini,P.Kashinathashastri,Reprint -2000. 7. Parikh s textbook of Medicinal Jurisprudence, 8. Parikh s textbook of Medicinal Jurisprudence, 9. Sharangdhaara Samhitaa, Pandit Parshuram Shashtri Chaukhambha Orientalia Varanasi, 5 th Edition, 2002. 10. Parikh s textbook of Medicinal Jurisprudence, 11. Parikh s textbook of Medicinal Jurisprudence, CORRESPONDING AUTHOR Dr. Chougule Savita Bhupal M.D. (Agadtantra) Asso. Prof., PG Department of Agadtantra, RIARCH, Mayani,Satara, Maharashtra, India Email: dr.savita15@gmail.com